Zevra Therapeutics, Inc. (ZVRA) Tops Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall St slumps as sharp tech losses put Nasdaq on course for correction
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts ZVRA Hot Sheet
Join SI Premium – FREE
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) reported Q1 EPS of ($0.40), $0.07 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $3.42 million versus the consensus estimate of $3.76 million.
For earnings history and earnings-related data on Zevra Therapeutics, Inc. (ZVRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- ScanSource (SCSC) Misses Q1 EPS by 25c ; Offers Guidance
- MACOM Technology Solutions (MTSI) Tops Q4 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
